Canada's Cannabis Act does not carve out a separate rule for artificial intelligence: the ban on promoting cannabis in section 17 and the ban on false, misleading, or deceptive promotion in section 18 apply to any ad, post, or chatbot reply, whether a person or a model wrote it. Public evidence that AI improves cannabis production, retail, or safety is thin, and the only audit of Canadian license holders' online promotion that this article could find was done by hand, not by software.
Key takeaways
- Section 17 of the Cannabis Act prohibits promotion unless the Act authorizes it, and section 18 prohibits false, misleading, or deceptive promotion.
- A 2021 JAMA Network Open audit of 261 licensed firms found at least one online promotion violation at 86.3 percent of the 211 firms that had an online platform.
- Federal license holders already report inventory and sales to Health Canada each month through a rule-based tracking system, and a streamlining order was proposed on September 26, 2026.
- Health Canada's 2024 survey put past-12-month use at 26 percent of people aged 16 and older, with the figures resting on self-report.
- No source found for this page shows an AI tool validated against Cannabis Act requirements, so vendor claims need independent checking.
What the Act says about promotion, whoever writes the copy
The Cannabis Act, sections 16 to 36, sets the promotion rules in plain terms. Section 17(1) says that, unless the Act authorizes it, promoting cannabis or a cannabis accessory is prohibited, including by communicating price or distribution information, appealing to young persons, using testimonials, or depicting people, characters, or animals. Section 17(2) allows informational and brand-preference promotion by authorized sellers and producers under conditions, such as placing it where young persons are not permitted by law or addressing an identified adult by name. Section 18 separately bars promotion that is false, misleading, or deceptive, and section 19 restricts terms, logos, and symbols set out in regulations.
None of this mentions how the content is produced. A marketing team that drafts social posts with a language model carries the same exposure as one that drafts them by hand, and a retailer's website chatbot that answers questions about price or products is subject to the same limits on what may be communicated. Whether a particular chatbot answer or generated caption is lawful is a legal question for counsel, not something this page can settle.
What the one compliance audit found
In July 2021, a cross-sectional study in JAMA Network Open by Natasha Sheikhan and colleagues examined how Canadian licensed firms promoted cannabis online. The team reviewed websites, Facebook, Instagram, and Twitter content collected between October 1, 2019, and March 31, 2020, for 261 firms; 211 of them had an online platform. Of those, 182 (86.3 percent) showed at least one violation. The most common problems were missing age restrictions (66.8 percent of firms with an online presence), glamorized branding (46.4 percent), and omitted risk information alongside a medical claim (33.6 percent). Violation rates were higher on Facebook and Instagram than on firms' own websites.
The authors listed their own limits: many firms held several licenses, age gates relied on an honor system, and risk information was counted only when paired with a medical claim. The work predates widespread use of generative AI in marketing, so it says nothing about AI-written content. Its relevance here is as a baseline: human-run promotion already produced frequent violations, and no figure in the study shows that software would raise or lower that rate.
Where AI could touch the sector, and what already governs it
The table is an orientation aid built from the sources listed below. The right-hand column states what was found, not what vendors say.
| Activity | Rule or data already in place | Public evidence found for AI |
|---|---|---|
| Drafting ads, posts, and product descriptions | Cannabis Act ss. 17 to 19 on promotion and false or misleading claims | None located; the 2021 audit was manual |
| Website or app chatbots | Same promotion rules; age-related conditions in s. 17(2) | None located |
| Inventory and sales reporting | Monthly reports to Health Canada through the Cannabis Tracking and Licensing System, using CSV forms | Health Canada's guidance describes validation checks, not AI |
| Measuring use among the public | Canadian Cannabis Survey, Health Canada, annual | Survey method is self-report; no AI role described |
The tracking system and a proposed change
Federal license holders for cultivation, processing, and sale for medical purposes file monthly reports with Health Canada, and private retailers and distributors report to their province or territory by the 10th of each month, according to Health Canada's cannabis tracking system page (last modified July 16, 2026). The guidance for license holders describes automatic checks, such as blocking a submission when opening inventory differs from the prior month's closing figure by more than five percent.
On September 26, 2026, the Canada Gazette, Part 1 published a proposed Order Amending the Cannabis Tracking System Order. It would cut the cannabis classes reported from 14 to 7, drop book-value and capacity reporting, and end reporting duties for provincial and territorial bodies and their authorized private distributors and retailers. Changes for federal license holders would take effect on January 1, 2028. The order is a proposal open to comment for 45 days, not a final rule. Nothing in the notice relies on AI.
What the usage data can and cannot show
Health Canada's Canadian Cannabis Survey page, last modified December 6, 2024, reports 2024 results: 26 percent of people aged 16 and older used cannabis in the past 12 months, unchanged from 2023 and up from 22 percent in 2018. Past-30-day use was 17 percent. Among past-12-month users, 72 percent usually bought from a legal source. Health Canada notes that respondents knew the survey concerned cannabis, which can bias who takes part, and answers are self-reported.
Those limits matter for AI claims. A tool that says it "predicts demand" or "detects underage use" needs a stated dataset, a test against known outcomes, and an error rate. Survey totals and license-holder reports do not supply those on their own.
Questions to put to any AI claim in this sector
- Which Cannabis Act provision does the tool address, and who checked the output against it?
- Is the evidence a peer-reviewed study, a regulator document, or a vendor case study?
- What data trained or tested the tool, and does it cover Canadian license holders?
- What was the error rate, including false negatives such as a missed violation?
- Who is accountable when generated content breaches the Act?
This article gives general information about law and public data. It is not medical or legal advice, and it does not encourage or discourage cannabis use. Questions about health, dosing, or interactions with other medicines belong with a physician or pharmacist, and questions about compliance belong with a lawyer or the primary sources below.
FAQ
Does the Cannabis Act regulate AI directly?
No provision found in sections 16 to 19 mentions AI. The promotion and false-claim rules apply to the content itself, regardless of how it was produced.
Can a licensed seller use a chatbot to answer customer questions?
The Act limits what may be communicated about price, distribution, and appeals to young persons, and section 17(2) sets conditions on permitted promotion. Whether a given chatbot design complies is a question for legal counsel.
Is there proof that AI makes cannabis safer or production more efficient?
None was located in regulator documents or peer-reviewed sources checked for this page. Company claims were not used.
Where can current cannabis rules be checked?
The Justice Laws website carries the Act, Health Canada publishes guidance and survey results, and provinces and territories set rules on retail and public consumption.
Related reading
- How GPHIN spots outbreaks
- Canada's 2026 business survey on AI tools
- U.S. Census data on AI use by sector
- Industry data on predictive maintenance
More in AI Policy and Ethics.
Last verified: October 2026
Sources
- Cannabis Act (S.C. 2018, c. 16), sections 16 to 19, Justice Laws Website, Government of Canada, 2026
- Sheikhan NY et al., Compliance With Cannabis Act Regulations Regarding Online Promotion Among Canadian Commercial Cannabis-Licensed Firms, JAMA Network Open, 2021
- Cannabis tracking system, Health Canada, modified July 16, 2026
- Order Amending the Cannabis Tracking System Order (Streamlining of Requirements), Canada Gazette, Part 1, Vol. 160, No. 39, September 26, 2026
- Cannabis use (non-medical) in Canada: key findings, Canadian Cannabis Survey, Health Canada, 2024 data, modified December 6, 2024